Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Jul 1;2(3):e23931.
doi: 10.4161/jkst.23931. Epub 2013 Jun 18.

Transcriptional regulation by STAT1 and STAT2 in the interferon JAK-STAT pathway

Affiliations
Review

Transcriptional regulation by STAT1 and STAT2 in the interferon JAK-STAT pathway

Nancy Au-Yeung et al. JAKSTAT. .

Abstract

STAT1 and STAT2 proteins are key mediators of type I and type III interferon (IFN) signaling, and are essential components of the cellular antiviral response and adaptive immunity. They associate with IFN regulatory factor 9 (IRF9) to form a heterotrimeric transcription factor complex known as ISGF3. The regulation of IFN-stimulated gene (ISG) expression has served as a model of JAK-STAT signaling and mammalian transcriptional regulation, but to date has primarily been analyzed at the single gene level. While many aspects of ISGF3-mediated gene regulation are thought to be common features applicable to several ISGs, there are also many reports of distinct cases of non-canonical STAT1 or STAT2 signaling events and distinct patterns of co-regulators that contribute to gene-specific transcription. Recent genome-wide studies have begun to uncover a more complete profile of ISG regulation, moving toward a genome-wide understanding of general mechanisms that underlie gene-specific behaviors.

Keywords: STAT1; STAT2; genome-wide; interferon; transcriptional regulation.

PubMed Disclaimer

Figures

None
Figure 1. Diagrammatic representation of transcription regulation in response to IFN stimulation. (A) Binding of type I or type III IFN to their cognate receptors initiates a signaling cascade that results in phosphorylation and heterodimerization of STAT1 and STAT2 and association with IRF9 to form the active transcription factor complex ISGF3. (B) STAT1 and STAT2 primarily associate to form ISGF3, but have also been reported to form other transcription factor complexes in response to IFN stimulation. These include AAF/GAF, U-STAT1, a STAT2/IRF9 complex, and ISGF3II. AAF/GAF has been widely reported to form in response to IFNα stimulation but the other complexes are less well understood. Accumulation of U-STAT1 has been shown to regulate ISG transcription; however, the structure and composition of the active transcription factor are not yet known. A STAT2/IRF9 complex has been reported to be transcriptionally active when overexpressed and ISGF3II has been identified in a single cell line. (C) ISGF3, the canonical transcription factor, regulates the transcription of many ISGs. However, the co-regulators necessary for gene expression vary from gene to gene. Three ISGs, ISG54, 9–27, and ISG15, are depicted here along with their gene-specific co-regulators as examples of the differential regulation in the IFN pathway.
None
Figure 2. ChIP-seq profile at ISG54, RUTBC3 and an unannotated locus. Sequence tag density signals from ENCODE ChIP-seq data sets are shown for untreated, 30 min IFNα-stimulated or 6 h IFNα-stimulated K562 cells (black) and GM12878 cells (gray). STAT1 and STAT2 occupancy is shown in the top portion at ISG54, a classical ISG (A), RUTBC3, a gene upregulated by IFNα (B) and an unannotated locus on chromosome 2 at position 146 449 900–146 451 900 (C). Co-occupancy at these loci by IRF1, c-Myc and c-Jun, is shown in the bottom portion of the figure. The individual tracks were auto-scaled to allow visualization of the binding pattern, especially when the signal differs drastically between loci. *Indicates data was not generated from the same experiment as the IFNα-stimulated data.

References

    1. Darnell JE, Jr., Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 1994;264:1415–21. doi: 10.1126/science.8197455. - DOI - PubMed
    1. Stark GR, Darnell JE., Jr. The JAK-STAT pathway at twenty. Immunity. 2012;36:503–14. doi: 10.1016/j.immuni.2012.03.013. - DOI - PMC - PubMed
    1. Meraz MA, White JM, Sheehan KC, Bach EA, Rodig SJ, Dighe AS, et al. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell. 1996;84:431–42. doi: 10.1016/S0092-8674(00)81288-X. - DOI - PubMed
    1. Durbin JE, Hackenmiller R, Simon MC, Levy DE. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell. 1996;84:443–50. doi: 10.1016/S0092-8674(00)81289-1. - DOI - PubMed
    1. García-Sastre A, Durbin RK, Zheng H, Palese P, Gertner R, Levy DE, et al. The role of interferon in influenza virus tissue tropism. J Virol. 1998;72:8550–8. - PMC - PubMed